Search Results for 'Sglt2-Level'

Sglt2-Level published presentations and documents on DocSlides.

SGLT2 Inhibitors and Their Clinical Impact:
SGLT2 Inhibitors and Their Clinical Impact:
by aaron
Ominous Octet. Renal Handling of Glucose. Active ...
Sglt2 inhibitor Dr.  NOUSHIN-KHALILI
Sglt2 inhibitor Dr. NOUSHIN-KHALILI
by roxanne
ENDOCRINOLOGIST. 97.12.7. Diabetes Prevalence in I...
Emerging CV Outcomes Trial Results: What Do They Mean for T2D Management?
Emerging CV Outcomes Trial Results: What Do They Mean for T2D Management?
by tatyana-admore
Expert Panelists. Program Goals. Evaluating CV Ri...
The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF)
The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF)
by ishaan
John McMurray. BHF Cardiovascular Research Centre,...
Highlights from ACC 2021
Highlights from ACC 2021
by maisie
Virtua – May 15-17, 2021. ACC 2021 Highlights . ...
Diabetes treatment options
Diabetes treatment options
by StarDust
Dr Theingi Aung. Endocrinologist. Royal Berkshire ...
Shifting Paradigms in the Selection of
Shifting Paradigms in the Selection of
by alyssa
Antidiabetes. Medications:. Cardiovascular Benefi...
Oral hypoglycemics Jennifer R Marks, MD
Oral hypoglycemics Jennifer R Marks, MD
by finley
Oral hypoglycemics. Factors to consider:. Cost. Av...
Journal Club 埼玉医科大学 総合医療センター 内分泌・糖尿病内科
Journal Club 埼玉医科大学 総合医療センター 内分泌・糖尿病内科
by jideborn
Department of Endocrinology and Diabetes, . Saitam...
 Diabetes and Hypertension Accelerate Glomerular Hypertension
Diabetes and Hypertension Accelerate Glomerular Hypertension
by aaron
Circulation 2014;129:587-597. Teaching Tool: Hype...
Type 1 Diabetes: Expanding Options for Adjunctive Oral Therapy With SGLT Inhibitors
Type 1 Diabetes: Expanding Options for Adjunctive Oral Therapy With SGLT Inhibitors
by yoshiko-marsland
Type 1 Diabetes: Expanding Options for Adjunctive...
Development Committee CHAIR
Development Committee CHAIR
by kittie-lecroy
Lawrence A. Leiter, Endocrinology & Metaboli...
Updates on CVOT Data and Clinical Comparisons That Matter
Updates on CVOT Data and Clinical Comparisons That Matter
by pamella-moone
This program will include a discussion of off-lab...
Updates Abound Introduction
Updates Abound Introduction
by sherrill-nordquist
GLP-1 RAs in Combination With Basal Insulin Appro...
How Effective Is Fixed-Dose Combination Therapy in T2D and Where Does It Fit?
How Effective Is Fixed-Dose Combination Therapy in T2D and Where Does It Fit?
by giovanna-bartolotta
Program Goals. Complementary Mechanism of Action ...
Oral Hypoglycemics
Oral Hypoglycemics
by danika-pritchard
Roland Halil, . BScPharm, ACPR, PharmD. Clinical ...
JARDIANCE:
JARDIANCE:
by sherrill-nordquist
Newly Approved Drug to Lower HbA1C in Type-2 diab...
FDA warns that SGLT2 inhibitors for diabetes may result in a serious c
FDA warns that SGLT2 inhibitors for diabetes may result in a serious c
by debby-jeon
DKA, a subset of ketoacidosis or ketosis in diabet...